Medullary Thyroid Cancer (MTC)

Also known as: Medullary thyroid cancer / Medullary Thyroid Carcinoma / C cell carcinoma / Medullary carcinoma of thyroid

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00188Bortezomib1 / 2Terminated1
DB13017Rovalpituzumab Tesirine1 / 2Active Not Recruiting1
DB05294Vandetanib1 / 2Active Not Recruiting1
DB05294Vandetanib1 / 2Terminated1
DB01356Lithium cation2Terminated1
DB09079Nintedanib2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting1
DB00398Sorafenib2Withdrawn1
DB11885Anlotinib2 / 3Completed1
DB05294Vandetanib3Active Not Recruiting1
DB05153Cabozantinib4Recruiting1
DB08875Cabozantinib4Recruiting1
DB08875CabozantinibNot AvailableApproved for Marketing1